The Jeonnam Bio Promotion Institute is connecting domestic bio materials, parts, and equipment companies with local bio firms in Hwasun to enhance the utilization of domestic products and strengthen bio manufacturing competitiveness.
On September 15, the Jeonnam Bio Promotion Institute, in collaboration with the Korea Bio Association and the Korea Bio Specialized Center Council, held the '2026 Domestic Bio Manufacturing Competitiveness Enhancement Bio Materials Company Presentation' at the Bio Pharmaceutical Headquarters.
The event aimed to introduce domestic bio materials technologies and products developed through research and development supported by the Ministry of Trade, Industry and Energy to local bio companies and related organizations, while expanding actual production applications and connections with demand companies.
Acting Director Yang Wan-gil emphasized that domestic bio materials technologies should not remain in the research and development stage but should be actively utilized in actual production sites, leveraging the institute's facilities, equipment, and business support capabilities.
Six domestic companies participated in the presentation, including Microdigital, CellSafe, Amicogen, Umtil, Excel Therapeutics, and J-O Tech. These companies showcased domestic technologies and products necessary for biopharmaceutical production, including antibody and cell/gene therapy culture media and resins, safety evaluation products, membrane filters, and animal cell culture equipment.
This event was part of a series of presentations held at four bio hubs across the country, including Siheung, Osong in North Chungcheong Province, Hwasun in Jeonnam, and Wonju in Gangwon Province.
The Jeonnam Bio Promotion Institute also introduced a 'Public CXO Service Platform' that connects services needed by companies during product development and production with public infrastructure.
The Public CXO integrates contract research (CRO), contract development (CDO), contract manufacturing (CMO), contract testing and analysis (CAO), specialized personnel training (CTO), and corporate support (CSO) into a comprehensive support system. It utilizes the facilities, equipment, and business support experience of the Bio Pharmaceutical Headquarters to provide the services companies need.
Bio materials refer to the materials, parts, and equipment necessary for biopharmaceutical production. As the domestic biopharmaceutical production base expands, securing a stable supply chain for key items and increasing the on-site utilization of domestic products are identified as major challenges.
Yang Wan-gil stated, "For the bio industry to continue to grow, it is essential to secure materials and equipment needed for production, in addition to developing new drugs. We will actively connect the institute's facilities, equipment, and business support experience to ensure that products made by domestic companies are utilized in actual production and lead to greater demand."
He added, "Hwasun is a place where bio companies, hospitals, research institutions, and production facilities are gathered, so we will continuously create opportunities for domestic materials companies and local bio firms to meet and engage in practical business cooperation."
Meanwhile, the Jeonnam Bio Promotion Institute plans to use this presentation as a stepping stone to expand exchanges between domestic bio materials companies and local bio firms, while supporting the application of domestic technologies and products in production sites and connections with demand companies to enhance domestic bio manufacturing competitiveness.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.